Le Lézard
Classified in: Health
Subjects: NPT, EXE

The CrowdCare Foundation Pledges Support for the Interoperability Rules Finalized by the US Department of Health and Human Services Today


SALT LAKE CITY, March 9, 2020 /PRNewswire/ -- The CrowdCare Foundation, a patient-driven, 501(c)(3) non-profit organization that empowers patients with rare diseases at each step of their disease journey, today pledged its support for the Interoperability Rules finalized by the U.S. Department of Health and Human Services (HHS). The rules require healthcare providers to grant patients free access to their own electronic health records and make it easier to coordinate patient care among facilities.

"We started the CrowdCare Foundation as a means to empower patients with the resources they need to treat their disease, and the new rules finalized by HHS today do just that," said Jenny Ahlstrom, founder of the CrowdCare Foundation. "When I was first diagnosed in 2010 with multiple myeloma, a rare form of blood cancer, I realized how difficult it was to navigate my own health records and treatment options. That's why we have since launched HealthTree®, an online platform for multiple myeloma that aggregates patient-contributed, anonymous data in order to help patients find their best treatment options and accelerate research towards a cure. There is no stakeholder that's in a better position to aggregate data and accelerate research than the patient. Patients need information, and they need it now; in many cases their lives depend on it."

The Interoperability Rules, which were first proposed on February 11, 2019, were finalized today. This past January a group of approximately 60 U.S. health systems signed a letter opposing the Interoperability Rules, citing concerns over patient privacy. Despite this opposition, the HHS has pushed the rules forward for patients.

"Patients today need to sign multiple forms before they get access to their own health records," said Ahlstrom. "Obtaining those records is not an easy process, and then the data doesn't come in a usable format. Companies making claims about patient privacy are concerned with protecting their own businesses, not curing diseases. If we are serious about curing cancer and other terminal diseases, then it is time we get serious about giving value back to the patient ? value in the form of information. We stand behind the HHS and believe that this decision is an imperative first step in empowering patients and pushing research forward."

HealthTree is free to myeloma patients. For more information, visit www.HealthTree.org.

About Myeloma Crowd/CrowdCare Foundation
The Myeloma Crowd is a division of the CrowdCare Foundation, a patient-driven 501(c)3 non-profit organization. The Myeloma Crowd provides patient education, advocacy and now research funding for multiple myeloma. Jennifer Ahlstrom founded the CrowdCare Foundation, Myeloma Crowd and also hosts online radio interviews with top myeloma specialists, live patient meetings and provides data solutions like HealthTree to drive to a cure. www.myelomacrowd.org

SOURCE Myeloma Crowd: CrowdCare Foundation


These press releases may also interest you

at 03:52
The progressive decrease in hearing in elderly people can represent a major problem for their quality of life: it has in fact been demonstrated that critical issues such as these, in addition to being a problem as such, can...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...



News published on and distributed by: